RATIO (CBA/VW AG)

Optimal result: 0.5 – 1 Ratio

The von Willebrand Factor Collagen Binding Activity to von Willebrand Factor Antigen ratio (vWF:CB/vWF:Ag) is a critical diagnostic parameter in the evaluation of von Willebrand Disease (VWD). This ratio provides essential information about the functional quality of von Willebrand Factor molecules relative to their quantity in circulation.

Von Willebrand Factor Collagen Binding Activity Ratio (vWF:CB/vWF:Ag)

The von Willebrand Factor Collagen Binding Activity to von Willebrand Factor Antigen ratio (vWF:CB/vWF:Ag) is a critical diagnostic parameter in the evaluation of von Willebrand Disease (VWD). This ratio provides essential information about the functional quality of von Willebrand Factor molecules relative to their quantity in circulation.

Understanding the Ratio

The vWF:CB/vWF:Ag ratio is calculated by dividing the collagen binding activity result by the von Willebrand Factor antigen level. A normal ratio typically falls between 0.7 and 1.2, though laboratory-specific reference ranges may vary. This ratio effectively normalizes the functional activity of vWF to its antigenic level, helping clinicians distinguish between quantitative and qualitative defects.

Clinical Significance

The ratio serves as a valuable diagnostic tool in several ways:

When the ratio is normal (≥0.7) but both values are proportionally decreased, this suggests Type 1 VWD, characterized by a quantitative deficiency where the existing vWF functions normally. In contrast, a decreased ratio (<0.7) with normal or low absolute values typically indicates Type 2 VWD, reflecting a qualitative defect in vWF function. Notably, a very low ratio may specifically suggest Type 2A or 2B VWD, where there is a selective loss of high-molecular-weight multimers.

Interpretation Considerations

Several factors can influence ratio interpretation. These include age, blood type, acute phase reactions, and certain medications. The ratio should always be interpreted within the context of other laboratory findings, clinical presentation, and patient history. Serial measurements may be necessary to establish consistent patterns, particularly in complex cases or when monitoring treatment response.

Applications in Patient Management

Clinicians use the vWF:CB/vWF:Ag ratio to guide treatment decisions and monitor therapeutic interventions. The ratio helps determine the most appropriate treatment approach, whether it involves desmopressin (DDAVP) or factor replacement therapy. During treatment, changes in the ratio can indicate therapeutic effectiveness and help adjust dosing regimens.

Technical Aspects

The accuracy of the ratio depends on precise measurement of both parameters. Modern automated platforms have improved standardization and reproducibility, but inter-laboratory variation remains a consideration. Quality control measures and regular calibration are essential for reliable ratio determination.

Future Perspectives

Ongoing research aims to refine the diagnostic utility of the vWF:CB/vWF:Ag ratio. Areas of investigation include establishing more precise cutoff values for different VWD subtypes, understanding the ratio's predictive value for bleeding risk, and developing standardized approaches to ratio interpretation across different laboratory methods and patient populations.

In conclusion, the vWF:CB/vWF:Ag ratio represents a sophisticated tool in the diagnosis and classification of VWD. Its careful interpretation, alongside other clinical and laboratory parameters, enables more accurate disease characterization and improved patient care.

RATIO (CBA/VW AG)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond RATIO (CBA/VW AG) — 10,000+ markers explained
One RATIO (CBA/VW AG) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro